Pluripotent stem cell-derived hepatocyte-like cells

Biotechnology Advances

Volumn 32, Issue 2, 2014, Pages 504-513

  Schwartz, R E ^a,c,d   Fleming, H E ^a,c   Khetani, S R ^e   Bhatia, S N ^a,b,c,d  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b USA   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Differentiation; Drug metabolism; Hepatocytes; IPSC; Liver; Stem cells

Indexed keywords

CELL CULTURE; DIAGNOSIS; DIFFERENTIATION (CALCULUS); DISEASE CONTROL; ENZYME INHIBITION; LIVER; METABOLISM; UREA;

DETOXIFICATION ENZYMES; DRUG METABOLISMS; HEPATOCYTE FUNCTIONS; HEPATOCYTES; HUMAN EMBRYONIC STEM (HES) CELLS; IPSC; LIVER TRANSPLANTATION; RENEWABLE SOURCES;

STEM CELLS;

CELL ORGANELLE; DISEASE PREVALENCE; DRUG; EMBRYONIC DEVELOPMENT; MATURATION; METABOLISM; PROTEIN; RENEWABLE RESOURCE; TOXICITY;

NORTH AMERICA;

IPS;

CELL DIFFERENTIATION; CYTOLOGY; DRUG METABOLISM; HEPATOCYTES, DIFFERENTIATION; HUMAN; IPSC; LIVER; LIVER CELL; PLURIPOTENT STEM CELL; REVIEW; STEM CELL;

DRUG METABOLISM; HEPATOCYTES, DIFFERENTIATION; IPSC; LIVER; STEM CELLS;

CELL DIFFERENTIATION; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIVER; PLURIPOTENT STEM CELLS;

EID: 84895469494     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.01.003     Document Type: Review

References (95)

1. Azuma H., Paulk N., Ranade A., Dorrell C., Al-Dhalimy M., Ellis E., et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007, 25:903-910.
2. Basma H., Soto-Gutierrez A., Yannam G.R., Liu L., Ito R., Yamamoto T., et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136:990-999.
3. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999, 13:1883-1900.
4. Bissell D.M., Arenson D.M., Maher J.J., Roll F.J. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. Eur J Clin Invest 1987, 79:801-812.
5. Castell J.V., Jover R., Martinez-Jimenez C.P., Gomez-Lechon M.J. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2006, 2:183-212.
6. Cayo M.A., Cai J., Delaforest A., Noto F.K., Nagaoka M., Clark B.S., et al. 'JD' iPS cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology 2012, 56(6):2163-2171.
7. Chan T.S., Yu H., Moore A., Khetani S.R., Tweedie D. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Drug Metab Dispos 2013, 41:2024-2032.
8. Chao P., Barminko J., Novik E., Han Y., Maguire T., Cheng K.C. Prediction of human hepatic clearance using an in vitro plated hepatocyte clearance model. Drug Metab Lett 2009, 3:296-307.
9. Chen A.A., Thomas D.K., Ong L.L., Schwartz R.E., Golub T.R., Bhatia S.N. Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A 2011, 108:11842-11847.
10. Cheng X., Ying L., Lu L., Galvao A.M., Mills J.A., Lin H.C., et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 2012, 10:371-384.
11. Chiao E., Elazar M., Xing Y., Xiong A., Kmet M., Millan M.T., et al. Isolation and transcriptional profiling of purified hepatic cells derived from human embryonic stem cells. Stem Cells 2008, 26:2032-2041.
12. Dalgetty D.M., Medine C.N., Iredale J.P., Hay D.C. Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol 2009, 297:G241-G248.
13. Daly A.K. Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annu Rev Pharmacol Toxicol 2012, 52:21-35.
14. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23:1534-1541.
15. Dandri M., Burda M.R., Torok E., Pollok J.M., Iwanska A., Sommer G., et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001, 33:981-988.
16. Deo R.C., MacRae C.A. The zebrafish: scalable in vivo modeling for systems biology. Wiley Interdiscip Rev Syst Biol Med 2011, 3:335-346.
17. Deutsch G., Jung J., Zheng M., Lora J., Zaret K.S. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001, 128:871-881.
18. Dhawan A., Strom S.C., Sokal E., Fox I.J. Human hepatocyte transplantation. Methods Mol Biol 2010, 640:525-534.
19. Dunn J.C., Yarmush M.L., Koebe H.G., Tompkins R.G. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 1989, 3:174-177.
20. Espejel S., Roll G.R., McLaughlin K.J., Lee A.Y., Zhang J.Y., Laird D.J., et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010, 120:3120-3126.
21. Flaim C.J., Chien S., Bhatia S.N. An extracellular matrix microarray for probing cellular differentiation. Nat Methods 2005, 2:119-125.
22. Folch A., Toner M. Microengineering of cellular interactions. Annu Rev Biomed Eng 2000, 2:227-256.
23. Fox I.J., Roy-Chowdhury J. Hepatocyte transplantation. J Hepatol 2004, 40:878-886.
24. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 338:1422-1426.
25. Fukuda J., Sakai Y., Nakazawa K. Novel hepatocyte culture system developed using microfabrication and collagen/polyethylene glycol microcontact printing. Biomaterials 2006, 27:1061-1070.
26. Gerets H.H., Tilmant K., Gerin B., Chanteux H., Depelchin B.O., Dhalluin S., et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 2012, 28:69-87.
27. Gonzalez S.A., Keeffe E.B. Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. Front Biosci 2011, 16:225-250.
28. Guillouzo A. Liver cell models in in vitro toxicology. Environ Health Perspect 1998, 106(Suppl. 2):511-532.
29. Hay D.C., Fletcher J., Payne C., Terrace J.D., Gallagher R.C., Snoeys J., et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A 2008, 105:12301-12306.
30. Huang P., He Z., Ji S., Sun H., Xiang D., Liu C., et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475:386-389.
31. Ito M., Nagata H., Miyakawa S., Fox I.J. Review of hepatocyte transplantation. J Hepatobiliary Pancreat Surg 2009, 16:97-100.
32. Jindal R., Nahmias Y., Tilles A.W., Berthiaume F., Yarmush M.L. Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J 2009, 23:2288-2298.
33. Khetani S.R., Bhatia S.N. Microscale culture of human liver cells for drug development. Nat Biotechnol 2008, 26:120-126.
34. Khetani S.R., Kanchagar C., Ukairo O., Krzyzewski S., Moore A., Shi J., et al. Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans. Toxicol Sci 2013, 132:107-117.
35. Khuu D.N., Scheers I., Ehnert S., Jazouli N., Nyabi O., Buc-Calderon P., et al. In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmacotoxicological testing. Cell Transplant 2011, 20:287-302.
36. Kobayashi N., Fujiwara T., Westerman K.A., Inoue Y., Sakaguchi M., Noguchi H., et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000, 287:1258-1262.
37. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov 2004, 3:711-715.
38. Lavon N. Generation of hepatocytes from human embryonic stem cells. Methods Mol Biol 2010, 640:237-246.
39. LeCluyse E.L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 2001, 13:343-368.
40. LeCluyse E.L., Audus K.L., Hochman J.H. Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol 1994, 266:C1764-C1774.
41. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367.
42. Lin P., Chan W.C., Badylak S.F., Bhatia S.N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng 2004, 10:1046-1053.
43. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
44. Liu H., Kim Y., Sharkis S., Marchionni L., Jang Y.Y. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med 2011, 3:82ra39.
45. Madan A., Graham R.A., Carroll K.M., Mudra D.R., Burton L.A., Krueger L.A., et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos: The Biol Fate Chem 2003, 31:421-431.
46. March S., Hui E.E., Underhill G.H., Khetani S., Bhatia S.N. Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology 2009, 50:920-928.
47. March S., Ng S., Velmurugan S., Galstian A., Shan J., Logan D.J., et al. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 2013, 14:104-115.
48. Matsumoto K., Yoshitomi H., Rossant J., Zaret K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294:559-563.
49. Michalopoulos G.K. Liver regeneration. J Cell Physiol 2007, 213:286-300.
50. Moore R.N., Dasgupta A., Rajaei N., Yarmush M.L., Toner M., Larue L., et al. Enhanced differentiation of embryonic stem cells using co-cultivation with hepatocytes. Biotechnol Bioeng 2008, 101:1332-1343.
51. Murray J.W., Thosani A.J., Wang P., Wolkoff A.W. Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp. Am J Physiol Gastrointest Liver Physiol 2011, 301:G60-G68.
52. Norton N., Li D., Rieder M.J., Siegfried J.D., Rampersaud E., Zuchner S., et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 2011, 88:273-282.
53. Nyberg S.L., Shatford R.A., Peshwa M.V., White J.G., Cerra F.B., Hu W.S. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 1993, 41:194-203.
54. Ogawa S., Surapisitchat J., Virtanen C., Ogawa M., Niapour M., Sugamori K.S., et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 2013, 140:3285-3296.
55. Ott J., Kamatani Y., Lathrop M. Family-based designs for genome-wide association studies. Nat Rev Genet 2011, 12:465-474.
56. Pattaro C., Kottgen A., Teumer A., Garnaas M., Boger C.A., Fuchsberger C., et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 2012, 8:e1002584.
57. Perera M.T., Mirza D.F., Elias E. Liver transplantation: issues for the next 20years. J Gastroenterol Hepatol 2009, 24(Suppl. 3):S124-S131.
58. Pillai V.C., Strom S.C., Caritis S.N., Venkataramanan R. A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS. J Pharmaceutical Biomed Anal 2013, 74:126-132.
59. Ploss A., Khetani S.R., Jones C.T., Syder A.J., Trehan K., Gaysinskaya V.A., et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 2010, 107:3141-3145.
60. Prot J.M., Videau O., Brochot C., Legallais C., Benech H., Leclerc E. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. Int J Pharmaceutics 2011, 408:67-75.
61. Rashid S.T., Corbineau S., Hannan N., Marciniak S.J., Miranda E., Alexander G., et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010, 120:3127-3136.
62. Schmouth J.F., Bonaguro R.J., Corso-Diaz X., Simpson E.M. Modelling human regulatory variation in mouse: finding the function in genome-wide association studies and whole-genome sequencing. PLoS Genet 2012, 8:e1002544.
63. Schofield P.N., Hoehndorf R., Gkoutos G.V. Mouse genetic and phenotypic resources for human genetics. Hum Mutat 2012, 33:826-836.
64. Schwartz R.E., Linehan J.L., Painschab M.S., Hu W.S., Verfaillie C.M., Kaufman D.S. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 2005, 14:643-655.
65. Schwartz R.E., Trehan K., Andrus L., Sheahan T.P., Ploss A., Duncan S.A., et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A 2012, 109:2544-2548.
66. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393.
67. Shan J., Schwartz R.E., Ross N.T., Logan D.J., Thomas D., Duncan S.A., et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol 2013, 9:514-520.
68. Sharma N.S., Wallenstein E.J., Novik E., Maguire T., Schloss R., Yarmush M.L. Enrichment of hepatocyte-like cells with upregulated metabolic and differentiated function derived from embryonic stem cells using S-NitrosoAcetylPenicillamine. Tissue Eng Part C Methods 2009, 15:297-306.
69. Si-Tayeb K., Noto F.K., Nagaoka M., Li J., Battle M.A., Duris C., et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51:297-305.
70. Soldner F., Laganiere J., Cheng A.W., Hockemeyer D., Gao Q., Alagappan R., et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011, 146:318-331.
71. Song Z., Cai J., Liu Y., Zhao D., Yong J., Duo S., et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009, 19:1233-1242.
72. Starzl T.E., Fung J.J. Themes of liver transplantation. Hepatology 2010, 51:1869-1884.
73. Starzl T.E., Groth C.G., Brettschneider L., Penn I., Fulginiti V.A., Moon J.B., et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968, 168:392-415.
74. Tada K., Roy-Chowdhury N., Prasad V., Kim B.H., Manchikalapudi P., Fox I.J., et al. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant 1998, 7:607-616.
75. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
76. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
77. Takebe T., Sekine K., Enomura M., Koike H., Kimura M., Ogaeri T., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013, 499:481-484.
78. Takebe T., Zhang R.R., Koike H., Kimura M., Yoshizawa E., Enomura M., et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 2014, 9:396-409.
79. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
80. Touboul T., Hannan N.R., Corbineau S., Martinez A., Martinet C., Branchereau S., et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 2010, 51:1754-1765.
81. Ubeaud G., Schiller C.D., Hurbin F., Jaeck D., Coassolo P. Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers. European J Drug Metab Pharmacokinetics 2001, 26:37-45.
82. Ungrin M.D., Joshi C., Nica A., Bauwens C., Zandstra P.W. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 2008, 3:e1565.
83. USDHHS, FDA, and CDER. Guidance for Industry Safety Testing of Drug Metabolites, 2008. http://wwwfdagov/OHRMS/DOCKETS/98fr/FDA-2008-D-0065-GDLpdf.
84. Vaclavikova R., Soucek P., Svobodova L., Anzenbacher P., Simek P., Guengerich F.P., et al. Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. Drug Metab Dispos: The Biol Fate Chem 2004, 32:666-674.
85. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-796.
86. Wandzioch E., Zaret K.S. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 2009, 324:1707-1710.
87. Wang W.W., Khetani S.R., Krzyzewski S., Duignan D.B., Obach R.S. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Drug Metab Dispos 2010, 38:1900-1905.
88. Wilkening S., Stahl F., Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003, 31:1035-1042.
89. Wu F.J., Friend J.R., Hsiao C.C., Zilliox M.J., Ko W.J., Cerra F.B., et al. Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng 1996, 50:404-415.
90. Wu F.J., Friend J.R., Remmel R.P., Cerra F.B., Hu W.S. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant 1999, 8:233-246.
91. Wu X., Robotham J.M., Lee E., Dalton S., Kneteman N.M., Gilbert D.M., et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog 2012, 8:e1002617.
92. Xu J.J., Henstock P.V., Dunn M.C., Smith A.R., Chabot J.R., de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci: An Official J Soc Toxicol 2008, 105:97-105.
93. Yu Y., Fisher J.E., Lillegard J.B., Rodysill B., Amiot B., Nyberg S.L. Cell therapies for liver diseases. Liver Transpl 2012, 18:9-21.
94. Zaret K.S., Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008, 322:1490-1494.
95. Zhang S., Chen S., Li W., Guo X., Zhao P., Xu J., et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum Mol Genet 2011, 20:3176-3187.